Francesca Cesari: Two registered clinical trials in Nature report the successful use of the GLP-1 and glucagon receptor co-agonist Mazdutide for type 2 diabetes.🧪 www.nature.com/articles/s41... www.nature.com/articles/s41...

See full post

Francesca Cesari francesari.bsky.social
Two registered clinical trials in Nature report the successful use of the GLP-1 and glucagon receptor co-agonist Mazdutide for type 2 diabetes.🧪 www.nature.com/articles/s41... www.nature.com/articles/s41...
Mazdutide versus placebo in Chinese adults with type 2 diabetes - Nature

Nature - Mazdutide versus placebo in Chinese adults with type 2 diabetes

nature.com
Dec 18, 2025 11:41
0 reposts 0 quotes 0 likes

View on Bluesky Show all post labels

An unhandled error has occurred. Reload 🗙